Overview Submission Instructions Recent Publications Frequently Asked Questions Research Topics

Looking to publish in Cardiovascular Therapeutics? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now

Cardiovascular Therapeutics

Cardiovascular Therapeutics is an open access journal publishing original research and review articles focusing on cardiovascular and clinical pharmacology, as well as clinical trials of novel cardiovascular therapies.

Looking to publish in Cardiovascular Therapeutics? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now

Subject Cardiac & Cardiovascular Systems, Pharmacology & Pharmacy

Impact Factor 3.4

Quartile Q2

Open Access Type Hybrid

ISSN 1755-5914

eISSN 1755-5922

Invitation Only No

Cost Range $2,380 USD / £1,750 GBP / €2,070 EUR APC if accepted and published

Submission Instructions

Cardiovascular Therapeutics accepts the following article types. Click on an article type to view submission instructions.

Original Research

Cover Letter Cover Letter requirements are not specified.

Abstract Original Research submissions must include a structured abstract. Abstract must not exceed 300 words. Abstract must be structured.

Manuscript Main text must be presented in the order Introduction, Materials and methods, Results and discussion, Conclusions. Manuscript must include no more than 7 keywords, and any use of artificial intelligence generated content tools must be described transparently and in detail in the Methods section.

References Original Research articles should cite more than 5 references. References must use a consistent style throughout the manuscript and include author names.

Figures & Tables The main document must be an editable .doc or .docx file including text and tables, and figures must be included as separate files or in a single PDF, Word document, or LaTeX suite. Each table must include a title and footnotes, and all figures must have accompanying legends and be numbered with Arabic numerals in the order they appear.

Reformat to Cardiovascular Therapeutics using Livewrite Premium

Review Article

Cover Letter Cover Letter requirements are not specified.

Abstract Review Articles must include an abstract. Review Article abstracts must be 250 words or fewer. Abstracts must be self-contained and citation-free.

Manuscript Review Articles are usually subdivided into thematic sections, and Narrative Reviews must not use traditional Research Article sections such as Materials and Methods or Results. The main document must be an editable .doc or .docx file including text and tables, must include a title page, no more than 7 keywords, references, tables, and figures, and must describe any use of AI-generated content tools in the Methods section.

References Review Articles should cite more than 10 references. References must use a consistent citation style throughout the manuscript. At least 50% of references must be journal articles, and the reference list must include author names.

Figures & Tables Figures must be uploaded as separate files or in a single PDF, Word document, or LaTeX suite, while the main editable document includes text and tables. Each table must include a title and footnotes, and all figures must have accompanying legends labeled with Arabic numerals in the order cited in the text.

Reformat to Cardiovascular Therapeutics using Livewrite Premium

Letter To The Editor

Cover Letter Cover Letter requirements are not specified.

Abstract Abstract requirements are not specified.

Manuscript Manuscript must include all required sections for the article. A statement specifying the contribution of every author must be provided, and any use of artificial intelligence generated content tools must be described transparently and in detail in the Methods section.

References At least 50% of the sources in the reference list must be journal articles. References must use a consistent style throughout the manuscript and include author names.

Figures & Tables Figures must be uploaded as separate files or in a single PDF, Word document, or LaTeX suite, and figure legends may be provided in a separate Figure Legend section in the main document after the references. All figures must have accompanying legends, be cited in the main text, and be numbered with Arabic numerals in the order they appear.

Reformat to Cardiovascular Therapeutics using Livewrite Premium

Editorial

Cover Letter Cover Letter requirements are not specified.

Abstract Abstract requirements are not specified.

Manuscript The manuscript must include a statement specifying the contribution of every author, and any use of artificial intelligence generated content tools must be described transparently and in detail in the Methods section.

References At least 50% of the sources in the reference list must be journal articles. References must use a consistent style throughout and include author names.

Reformat to Cardiovascular Therapeutics using Livewrite Premium

Recent Publications

Safety and Feasibility of a Novel Split Design Left Atrial Appendage Occluder: From Preclinical Investigations to First‐in‐Human Application

Mingfei Li, Dawei Lin, Lei Zhang, Yuan Zhang, Wenzhi Pan, Xiaochun Zhang, Daxin Zhou, Junbo Ge

10.1155/cdr/1340277

View Publication

Systematic Pharmacology Combined With Experimental Validation Reveals the Apoptosis‐Related Mechanism of Simiao Yong′an (SMYA) Decoction Against Myocardial Ischemia‐Reperfusion Injury

Huanjie Fu, Eryue Liu, Hao Yu, Yisheng Zhao, Yongkang Gan, Jinhong Chen, Zhichao Liu

10.1155/cdr/4200440

View Publication

Association Between HALP Score and Atrial Fibrillation Recurrence After Radiofrequency Catheter Ablation

Qing Yan, Yide Yuan, Yuyang Zhao, Lan Yang, Jiali Fan, Jiahong Xue, Qiangsun Zheng

10.1155/cdr/4538055

View Publication

Genetic Evidence Linking Inflammatory Cytokines and Blood Metabolites to Heart Failure Risk

Yanbing Yao, Linghui Tang, Peilin Zhou, Feng Huang, Zhiyu Zeng

10.1155/cdr/6340671

View Publication

Direct or Indirect Action? Mechanisms of the Antiatherosclerotic Effects of Glucagon‐Like Peptide‐1 Receptor Agonists

Michał Zawadzki, Monika Karczewska-Kupczewska

10.1155/cdr/8388511

View Publication

Frequently asked questions

How long does it take to publish?

Median submission to first decision is 61 days, submission to acceptance is 191 days, and acceptance to publication is 28 days.

Reformat to Cardiovascular Therapeutics using Livewrite Premium

Is a cover letter required?

Cover letters are not mandatory. Authors may upload a short cover letter as a separate document at submission to explain the rationale for the submission and its contribution.

Reformat to Cardiovascular Therapeutics using Livewrite Premium

What are the publication costs?

Article publication charge: $2,380 USD / £1,750 GBP / €2,070 EUR for accepted and published articles.

Reformat to Cardiovascular Therapeutics using Livewrite Premium

Research Topics

Atrial Fibrillation Management and Outcomes Lipoproteins and Cardiovascular Health Heart Failure Treatment and Management Cardiovascular Function and Risk Factors Antiplatelet Therapy and Cardiovascular Diseases Cardiac Fibrosis and Remodeling Cardiac electrophysiology and arrhythmias Coronary Interventions and Diagnostics Blood Pressure and Hypertension Studies Acute Myocardial Infarction Research Cardiac Ischemia and Reperfusion Cardiac Arrhythmias and Treatments Hormonal Regulation and Hypertension Cardiac Imaging and Diagnostics Cardiac Valve Diseases and Treatments Heart Rate Variability and Autonomic Control Diabetes, Cardiovascular Risks, and Lipoproteins Cardiac pacing and defibrillation studies Venous Thromboembolism Diagnosis and Management Diabetes Treatment and Management Heart rate and cardiovascular health Cardiovascular Disease and Adiposity Pulmonary Hypertension Research and Treatments Cardiovascular Health and Disease Prevention Atherosclerosis and Cardiovascular Diseases

Related Journals

Drug Resistance Updates Elsevier BV

Journal of Pharmacology and Experimental Therapeutics American Society for Pharmacology and Experimental Therapeutics

European Neuropsychopharmacology Elsevier BV

Clinical Medicine Insights Cardiology SAGE Publishing

Pharmaceutical Biology Taylor & Francis

JACC Heart Failure Elsevier BV